Aura Biosciences to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Aura Biosciences (NASDAQ:AURA), a clinical-stage biotech developing precision therapies for solid tumors, will participate in two May 2026 investor conferences.

Management will host fireside chats at the H.C. Wainwright BioConnect Conference and the TD Cowen Oncology Innovation Summit, with live webcasts and 90-day replays on the company’s investor website.

News Market Reaction – AURA

+1.13%

1 alert

+1.13% Session close to close

$855.56M Market Cap

0.1x Rel. Volume

In the May 13 session, AURA gained 1.13%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that members of its senior management team will participate in the following upcoming investor conferences:

• H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq on Tuesday, May 19, 2026.
  
  

Fireside Chat at 12:00 p.m. ET

• TD Cowen 7^th Annual Oncology Innovation Summit: Insights for ASCO & EHA on Wednesday, May 27, 2026.
  
  

Fireside Chat at 1:30 p.m. ET

The live webcasts of the fireside chats will be available on the “Investors & Media” page under the “Events & Presentations” section of the Company’s website at https://ir.aurabiosciences.com/events-and-presentations, where a replay of each webcast will be archived for 90 days following the presentation date.

About Aura Biosciences

Aura Biosciences, Inc. is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Aura’s lead candidate, bel-sar (AU-011), is currently in late-stage development for early choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer. Aura is headquartered in Boston, MA. Aura’s mission is to grow as an innovative global oncology company that positively transforms the lives of patients.

For more information, visit aurabiosciences.com. Follow us on X, @AuraBiosciences, and visit us on LinkedIn.

Investor and Media Relations Contact:

Alex Dasalla

Head of Investor Relations and Corporate Communications

IR@aurabiosciences.com

FAQ

When will Aura Biosciences (NASDAQ:AURA) present at the H.C. Wainwright 4th Annual BioConnect Investor Conference?

Aura Biosciences will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference on Tuesday, May 19, 2026, with a fireside chat at 12:00 p.m. ET. According to Aura Biosciences, a live webcast and 90-day replay will be available online.

What is the date and time of Aura Biosciences’ fireside chat at the TD Cowen Oncology Innovation Summit 2026?

Aura Biosciences’ fireside chat at the TD Cowen 7th Annual Oncology Innovation Summit is scheduled for Wednesday, May 27, 2026, at 1:30 p.m. ET. According to Aura Biosciences, investors can access the live webcast and replay via the company’s investor relations website.

How can investors watch Aura Biosciences’ May 2026 investor conference webcasts?

Investors can watch Aura Biosciences’ May 2026 conference webcasts via live streaming on the company’s website. According to Aura Biosciences, links are on the “Investors & Media” page under “Events & Presentations,” with replays archived for 90 days.

Where will replays of Aura Biosciences’ May 2026 investor presentations be available?

Replays of Aura Biosciences’ May 2026 investor presentations will be available on its investor relations website. According to Aura Biosciences, each fireside chat replay will be archived for 90 days in the “Events & Presentations” section.

What type of company is Aura Biosciences (AURA) and what will it discuss at these conferences?

Aura Biosciences is a clinical-stage biotechnology company developing precision therapies for solid tumors. According to Aura Biosciences, senior management will participate in fireside chats at two oncology-focused investor conferences, offering updates and insights for investors.